Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flamirins is an isotonic buffered wound cleanser developed and marketed by Flen Health for the management of acute and chronic wounds. Formulated as a topical spray, it contains polysorbate, a surfactant that reduces surface tension between fluids and the wound bed to facilitate mechanical debridement of non-viable tissue and foreign bodies. It also incorporates citric acid to maintain an acidic pH environment, which creates conditions less conducive to bacterial growth. The solution is designed to be non-stinging and can be applied in either spray or stream modes to effectively clean the wound micro-environment and reduce the risk of infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Flamirins.